Brown Brian Lee 4
4 · Co-Diagnostics, Inc. · Filed May 24, 2023
Insider Transaction Report
Form 4
Brown Brian Lee
Chief Financial Officer
Transactions
- Disposition to Issuer
Common Stock
2023-05-23$1.32/sh−26,057$34,395→ 131,013 total - Award
Common Stock
2023-05-23+80,834→ 157,070 total - Exercise/Conversion
Restricted Stock Units
2023-05-23−80,834→ 521,666 totalExercise: $0.00→ Common Stock (602,500 underlying)
Footnotes (2)
- [F1]Included in 30,000 restricted stock units awarded to the Reporting Person on February 22, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on May 24, 2021. Included in 100,000 restricted stock units awarded to the Reporting Person on August 12, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2021. Included in 225,000 restricted stock units awarded to the Reporting Person on June 6, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2022. Included in 130,000 restricted stock units awarded to the Reporting Person on January 17, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on May 23, 2023.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.